<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE paragraph
  PUBLIC "-//IFRS//DTD DITA Paragraph//EN" "../../../../DocTypes/com.ifrs.doctype/dtd/paragraph.dtd">
<paragraph id="IFRS01_BC89"><paranum>BC89</paranum><prolog><data name="standard_number" value="IFRS 1"/><data name="paranum" value="BC89"/></prolog><body><variant base="F19755480" id="IFRS01_BC89_V2" principles="no"> <p id="IFRS01_P2906">Some respondents to ED 1 suggested that it would be onerous to prepare comparative information in accordance with <xref base="F19755481" href="../ias32/IAS32_TOC.dita#IAS32_TOC0001" id="IFRS01_X1831">IAS 32</xref> and <xref base="F19755482" href="../ias39/IAS39_TOC.dita#IAS39_TOC0001" id="IFRS01_X1832">IAS 39</xref><xref keyref="footnotes/IFRS01_FN0044" type="fn"/> about financial instruments. They suggested that an entity should be able to apply IAS 39 prospectively from the beginning of the year of its first IFRS financial statements (eg 1 January 2005 for many first&#x2011;time adopters). They noted that US companies were not required to restate comparatives on the introduction of SFAS 133 <ph outputclass="standard_ref"><ph outputclass="standard_title">Accounting for Derivative Instruments and Hedging Activities</ph></ph>. However, given the Board&#x2019;s emphasis on comparability within the first IFRS financial statements (<xref base="F19755485" href="IFRS01_BC10.dita#IFRS01_BC10" id="IFRS01_X1833">paragraph BC10</xref>) and the assumption of timely planning (<xref base="F19755486" href="IFRS01_BC27.dita#IFRS01_BC27" id="IFRS01_X1834">paragraph BC27</xref>), the Board introduced no general exemption in this area.</p></variant></body></paragraph>